Physician profile
Samuel E Thomas
NPI 1538588769
$19,674.18
in general payments reported to CMS, 2019-2025
28 companies · $2,033 in 2025
The $2,033 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,215 · 2020: $2,455 · 2021: $5,994 · 2022: $3,064 · 2023: $2,074 · 2024: $839 · 2025: $2,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780 · Travel and Lodging: $2,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.18 |
| Travel and Lodging | $2,166.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,046.07 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Accolade |
| Arthrex, INC. | $4,966.78 | 2021-2025 | |
| Exactech, INC. | $2,879.86 | 2019 | |
| Peerless Surgical INC. | $2,207.75 | 2021 | |
| Microport Orthopedics INC | $1,774.47 | 2020 | |
| Medical Device Business Services, INC. | $904.71 | 2020-2022 | |
| Depuy Synthes Sales INC. | $651.33 | 2020-2025 | Na, Tfn-Advance |
| Coastal Medical Technologies LLC | $352.87 | 2023-2025 | |
| Smith+Nephew, INC. | $253.68 | 2022-2025 | Pico, Renasys Touch, Evos |
| Amgen INC. | $129.04 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $53.39 | 2021-2024 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $50.00 | 2019 | |
| Bioventus LLC | $48.65 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Baxter Healthcare | $43.33 | 2023 | Floseal |
| Mvp Orthopedics INC | $36.00 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $27.54 | 2025 | |
| Atricure, INC. | $27.50 | 2024 | |
| Orthofix Medical, INC. | $26.11 | 2021 | |
| Avanos Medical | $25.32 | 2019 | |
| Djo, LLC | $25.22 | 2025 | Cmf |
| Ferring Pharmaceuticals INC. | $24.85 | 2022 | |
| Abbott Laboratories | $21.35 | 2023 | Proclaim |
| Solventum Corporation | $21.03 | 2025 | V.A.C.Ulta, Prevena |
| Curonix LLC | $16.98 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $16.20 | 2025 | Hymovis, Triluron |
| Trice Medical, INC. | $15.24 | 2022 | |
| Heraeus Medical, LLC. | $14.62 | 2023 | Palacos |
| Ethicon US, LLC | $14.29 | 2023 | Stratafix, Echelon Circular, Dermabond Prineo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.